BDBM425938 US10512644, Compound 6-O-mPEG8-Nalbuphine
SMILES: COCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45
InChI Key: InChIKey=WUWLKBBKVXRTJE-ZOONCDFMSA-N
Data: 2 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM425938![]() (US10512644, Compound 6-O-mPEG8-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | 79.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inheris Pharmaceuticals, Inc. US Patent | Assay Description Briefly, the receptor binding affinity of the nalbuphine and PEG-nalbuphine conjugates was measured using radioligand binding assays in CHO cells tha... | US Patent US10512644 (2019) BindingDB Entry DOI: 10.7270/Q2RN3B8V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM425938![]() (US10512644, Compound 6-O-mPEG8-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | 168 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inheris Pharmaceuticals, Inc. US Patent | Assay Description Briefly, the receptor binding affinity of the nalbuphine and PEG-nalbuphine conjugates was measured using radioligand binding assays in CHO cells tha... | US Patent US10512644 (2019) BindingDB Entry DOI: 10.7270/Q2RN3B8V | |||||||||||
More data for this Ligand-Target Pair |